Not recruiting
Investigational
Study on Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Investigational
- Substances:Batoclimab
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Batoclimab
Find therapies in clinical trials near you – page 2
- recruiting
- 3 961
- countries
- 28
- conditions
- 2 103
3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today
17 trials match your criteria
Not recruiting
Registered drug
Study on the Effectiveness and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Registered drug
- Substances:NipocalimabHuman Normal Immunoglobulin
Countries:
Czechia
Czechia- Participants:18–64 years · 65+ years
- Substances:Nipocalimab
Not recruiting
Investigational
Study on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments
Investigational
- Substances:Riliprubart
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Riliprubart
Not recruiting
InvestigationalNo placebo
Study on the Effects of Riliprubart for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
InvestigationalNo placebo
- Substances:Riliprubart
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Riliprubart
Not recruiting
Registered drugNo placebo
Study Comparing Subcutaneous and Intravenous Human Normal Immunoglobulin for New Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Registered drugNo placebo
- Substances:Human Normal Immunoglobulin
Countries:
Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Human Normal Immunoglobulin